Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Mar 06  •  04:00PM ET
90.90
Dollar change
-2.11
Percentage change
-2.27
%
Mar 05, 7:35 PMMedtronic subsidiary MiniMed prices IPO at $20 per share for 28 million shares, to retain roughly 90% ownership
IndexS&P 500 P/E25.38 EPS (ttm)3.58 Insider Own- Shs Outstand1.28B Perf Week-6.92%
Market Cap116.71B Forward P/E14.92 EPS next Y6.09 Insider Trans- Shs Float1.28B Perf Month-10.74%
Enterprise Value136.60B PEG2.47 EPS next Q1.67 Inst Own87.25% Short Float1.35% Perf Quarter-10.86%
Income4.61B P/S3.29 EPS this Y2.86% Inst Trans0.35% Short Ratio2.24 Perf Half Y-2.10%
Sales35.48B P/B2.38 EPS next Y7.87% ROA5.09% Short Interest17.33M Perf YTD-5.37%
Book/sh38.17 P/C13.92 EPS next 5Y6.04% ROE9.38% 52W High106.33 -14.51% Perf Year-2.39%
Cash/sh6.53 P/FCF21.57 EPS past 3/5Y-1.03% 0.39% ROIC6.00% 52W Low79.55 14.27% Perf 3Y10.95%
Dividend Est.2.79 (3.07%) EV/EBITDA14.30 Sales past 3/5Y1.91% 3.01% Gross Margin59.59% Volatility2.21% 2.19% Perf 5Y-23.14%
Dividend TTM2.83 (3.11%) EV/Sales3.85 EPS Y/Y TTM9.06% Oper. Margin18.23% ATR (14)2.20 Perf 10Y20.22%
Dividend Ex-DateMar 27, 2026 Quick Ratio1.87 Sales Y/Y TTM6.88% Profit Margin13.00% RSI (14)27.61 Recom1.85
Dividend Gr. 3/5Y3.57% 5.33% Current Ratio2.54 EPS Q/Q-11.90% SMA20-7.14% Beta0.73 Target Price112.32
Payout77.47% Debt/Eq0.57 Sales Q/Q8.74% SMA50-7.87% Rel Volume1.39 Prev Close93.01
Employees95000 LT Debt/Eq0.57 EarningsFeb 17 BMO SMA200-3.53% Avg Volume7.74M Price90.90
IPONov 21, 1977 Option/ShortYes / Yes EPS/Sales Surpr.1.74% 1.19% Trades Volume10,749,095 Change-2.27%
Date Action Analyst Rating Change Price Target Change
Feb-13-26Resumed Barclays Overweight $116
Feb-09-26Upgrade Needham Hold → Buy $121
Feb-03-26Resumed Citigroup Buy $117
Jan-30-26Resumed Wells Fargo Overweight $114
Jan-06-26Upgrade William Blair Mkt Perform → Outperform
Nov-19-25Upgrade Goldman Sell → Neutral $111
Jun-30-25Upgrade Wolfe Research Underperform → Peer Perform
Jun-16-25Initiated Leerink Partners Outperform $110
Mar-04-25Upgrade Citigroup Neutral → Buy $92 → $107
Oct-10-24Upgrade RBC Capital Mkts Sector Perform → Outperform $98 → $105
Today 02:53PM
10:30AM
09:00AM
Mar-05-26 07:33PM
04:53PM
05:03AM Loading…
05:03AM
Mar-04-26 12:38AM
Mar-03-26 11:30AM
10:31AM
10:15AM
09:10AM
Feb-26-26 11:21AM
08:14AM
Feb-25-26 08:30AM
07:31AM
12:02PM Loading…
Feb-24-26 12:02PM
11:33AM
10:42AM
10:27AM
08:30AM
08:00AM
06:25AM
Feb-23-26 03:33PM
01:13PM
12:25PM
12:25PM
05:56AM
Feb-21-26 07:00AM
Feb-20-26 05:46AM
05:41AM
11:01AM Loading…
Feb-19-26 11:01AM
Feb-18-26 09:50AM
08:18AM
07:51AM
Feb-17-26 06:18PM
05:01PM
04:33PM
04:25PM
04:21PM
02:09PM
02:00PM
01:46PM
12:32PM
11:22AM
11:11AM
10:48AM
10:35AM
10:20AM
09:42AM
09:41AM
09:40AM
09:34AM
09:34AM
09:30AM
09:21AM
07:55AM
07:40AM
07:27AM
07:05AM
06:53AM
06:45AM
06:44AM
03:45AM
03:45AM
Feb-16-26 09:55AM
09:42AM
07:00AM
Feb-15-26 01:00PM
07:57AM
Feb-13-26 07:00PM
03:30PM
11:04AM
09:49AM
08:38AM
08:01AM
08:00AM
Feb-11-26 01:56PM
11:14AM
09:15AM
Feb-09-26 05:45PM
10:54AM
09:36AM
08:02AM
07:43AM
Feb-06-26 01:14PM
Feb-05-26 02:21PM
Feb-04-26 06:42AM
Feb-03-26 05:55PM
12:21PM
11:18AM
08:17AM
08:00AM
06:11AM
Feb-02-26 11:08AM
09:17AM
Jan-30-26 05:50PM
05:10PM
02:31PM
09:54AM
07:59AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIIL HARRY SKIPEVP & President CardiovascularFeb 19 '26Option Exercise90.9050,8764,624,51285,292Feb 26 05:48 PM
KIIL HARRY SKIPEVP & President CardiovascularFeb 19 '26Sale97.7152,5245,132,21732,768Feb 26 05:48 PM
KIIL HARRY SKIPOfficerFeb 19 '26Proposed Sale97.7152,5245,132,217Feb 19 03:19 PM
Smith Gregory LEVP Global Ops & Supply ChainNov 19 '25Sale101.9530,0003,058,45146,016Nov 21 04:13 PM
Smith Gregory LOfficerNov 19 '25Proposed Sale101.9530,0003,058,452Nov 19 11:05 AM
KIIL HARRY SKIPEVP & President CardiovascularSep 03 '25Sale91.588,605788,04835,615Sep 05 04:18 PM
KIIL HARRY SKIPOfficerSep 03 '25Proposed Sale91.588,605788,049Sep 03 03:23 PM
Jellison William RDirectorAug 22 '25Buy92.732,500231,8252,500Aug 25 05:18 PM
Jellison William RDirectorAug 25 '25Buy92.372,500230,9255,000Aug 25 05:18 PM
Walter Matthew R.SVP, Chief HR OfficerAug 01 '25Option Exercise23.913,14275,11432,804Aug 04 04:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 01 '25Option Exercise0.0015,249066,531Aug 04 04:20 PM
Smith Gregory LEVP Global Ops & Supply ChainAug 01 '25Option Exercise0.0011,328083,071Aug 04 04:19 PM
Martha GeoffreyChairman and CEOAug 01 '25Option Exercise32.2198,3243,166,800284,923Aug 04 04:18 PM
Marinaro MichaelEVP, Pres MedSurg and AmericasAug 01 '25Option Exercise25.249,661243,82857,628Aug 04 04:17 PM
KIIL HARRY SKIPEVP & President CardiovascularAug 01 '25Option Exercise0.0010,457051,775Aug 04 04:16 PM
Blomquist Denise L.Chief Accounting OfficerAug 01 '25Option Exercise32.2251816,69212,671Aug 04 04:15 PM
Salmon SeanOfficerJun 06 '25Proposed Sale86.8118,3781,595,469Jun 06 02:43 PM